Journal Flyer

Archives of Clinical Case Studies - ACCS

ISSN: 2687-8410

Managing Editor: Crystal Waston

Contact us at:

Open Access Case Report

Chemotherapeutic Prevention of Choriocarcinoma Developed in Persistent Trophoblastic Disease after Hydatidiform Mole

Kazuo Maeda*

Tottori University Med School, Japan

Corresponding Author

Received Date: March 21, 2019;  Published Date: April 18, 2019

Abstract

The author treated choriocarcinoma (Ch-C) with systemic primary Methotrexate (MTX) and achieved complete remission with the disappearance of primary and metastatic foci by repeated 200 to 300 mg intensive MTX courses, confirmed by the loss of human chorionic gnadotropine (hCG) in the serum and urine. Thus, the author intended to prevent choriocarcinoma (Ch-C) with MTX chemotherapy.

Article Details
Citation

  • Kazuo Maeda. Chemotherapeutic Prevention of Choriocarcinoma Developed in Persistent Trophoblastic Disease after Hydatidiform Mole. Arch Clin Case Stud. 1(3): 2019. ACCS.MS.ID.000513.

Signup for Newsletter
  • newsletter-subscription
© 2018 Iris Publishers LLC, All rights reserved. No part of this content may be reproduced or transmitted in any form or by any means as per the standard guidelines of fair use. Creative Commons License Open Access by
Iris Publishers LLC is licensed under Creative Commons License a Creative Commons Attribution 4.0 International License. Based on a work at www.irispublishers.com. Best viewed in browser_icons browser_icons | Above IE 9.0 version | Privacy Policy
Scroll to Top